Abstract
CD40 is a 50-kDa glycoprotein expressed on B-cells, monocytes, dendritic cells, follicular dendritic cells, thymic epithelial cells, and certain carcinomas (for review, see ref. 1). Its counterstructure, CD40 ligand (CD40L), is a 33-kDa glycoprotein expressed primarily on activated CD4+ T-cells, but also found on CD8+ T-cells, mast cells, basophils (1), and eosinophils (2). CD40L belongs to the tumor necrosis factor (TNF) superfamily (3), members of which stimulate a broad range of biological functions including proliferation, induction of cytokine secretion, and apoptosis (For review, see ref. 4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Banchereau, J., Bazan, F., Blanchard, D., Brière, F., Galizzi, J. P., van Kooten, C., Liu, Y. J., Rousset, F., and Saeland, S. (1994) The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881–922.
Gauchat, J.-F., Henchoz, S., Fattah, D., Mazzei, G., Aubry, J.-P., Jomotte, T., Dash, L., Page, K., Solari, R., Aldebert, D., Capron, M., Dahinden, C., and Bonnefoy, J.-Y. (1995) CD40 ligand is functionally expressed on human eosinophils. Eur. J. Immunol. 25, 863–865.
Armitage, R. J., Fanslow, W. C., Strockbine, LL., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., Clark, E. A., Smith, C. A., Grabstein, K. H., Cosman, D., and Spriggs, M. K. (1992) Molecular and biological characterization of a murine ligand for CD40. Nature 357, 80–82.
Alderson, M. R. (1994) Regulation of immune responses by the ligands for CD27, CD30 and 4–1BB. Circ. Shock 44, 73–76.
Noelle, R. J., Ledbetter, J. A., and Aruffo, A. (1992) CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol. Today 13, 431–433.
Durie, F. H., Foy, T. M., Masters, S. R., Laman, J. D., and Noelle, R. J. (1994) The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15, 406–411.
Hirohata, S., Jelinek, D. F., and Lipsky, P. E. (1988) T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3. J. Immunol. 140, 3736–3744.
Bartlett, W. C., Michael, A., McCann, J., Yuan, D., Claassen, E., and Noelle, R. J. (1989) Cognate interactions between helper T cells and B cells. II. Dissection of cognate help by using a class II-restricted, antigen-specific, IL2-dependent helper T cell clone. J. Immunol. 143, 1745–1754.
Hodgkin, P. D., Yamashita, L. C., Coffman, R. L., and Kehry, M. R. (1990) Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. J. Immunol. 145, 2025–2034.
Brian, A. A. (1988) Stimulation of B-cell proliferation by membrane-associated molecules from activated T cells. Proc. Natl. Acad. Sci. USA 85, 561 568.
Bartlett, W. C., McCann, J., Shepherd, D. M., Roy, M., and Noelle, R. J. (1990) Cognate interactions between helper T cells and B cells. IV. Requirements for the expression of effector phase activity by helper T cells. J. Immunol. 145, 3956–3962.
Clark, E. A. and Ledbetter, J. A. (1986) Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. USA 83, 4494–4498.
Banchereau, J., de Paoli, P., Vallé, A., Garcia, E., and Rousset, F. (1991) Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251, 70–72.
Jabara, H. H., Fu, S. M., Geha, R. S., and Vercelli, D. (1990) CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172, 1861–1864.
Spriggs, M. K., Armitage, R. J., Strockbine, L., Clifford, K. N., Macduff, B. M., Sato, T. A., Maliszewski, C. R., and Fanslow, W. C. (1992) Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176, 1543–1550.
Hollenbaugh, D., Grosmaire, L. S., Kullas, C. D., Chalupny, N. J., BraeschAndersen, S., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A., and Aruffo, A. (1992) The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 11, 4313–4321.
Alderson, M. R., Armitage, R. J., Tough, T. W., Strockbine, L., Fanslow, W. C., and Spriggs, M. K. (1993) CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178, 669–674.
Wagner, D. H., Jr., Stout, R. D., and Suttles, J. (1994) Role of the CD40CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur. J. Immunol. 24, 3148–3154.
Shu, U., Kiniwa, M., Wu, C. Y., Maliszewski, C., Vezzio, N., Hakimi, J., Gately, M., and Delespesse, G. (1995) Activated T cells induce interleukin12 production by monocytes via CD40—CD40 ligand interaction. Eur. J. Immunol. 25, 1125–1128.
Ranheim, E. A. and Kipps, T. J. (1993) Activated T cells induce expression of B7/BB 1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177, 925–935.
Armitage, R. J., Maliszewski, C. R., Alderson, M. R., Grabstein, K. H., Spriggs, M. K., and Fanslow, W. C. (1993) CD40L: a multi-functional ligand. Semin. Immunol. 5, 401–412.
Klaus, S. J., Pinchuk, L. M., Ochs, H. D., Law, C.-L., Fanslow, W. C., Armitage, R. J., and Clark, E. A. (1994) Costimulation through CD28 enhances T cell-dependent B cell activation via a CD40—CD40L interaction. J. Immunol. 152, 5643–5652.
Foy, T. M., Shepherd, D. M., Durie, F. H., Aruffo, A., Ledbetter, J. A., and Noelle, R. J. (1993) In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178, 1567–1575.
Foy, T. M., Laman, J. D., Ledbetter, J. A., Aruffo, A., Claassen, E., and Noelle, R. J. (1994) gp39—CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180, 157–163.
Durie, F. H., Fava, R. A., Foy, T. M., Aruffo, A., Ledbetter, J. A., and Noelle, R. J. (1993) Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261, 1328–1330.
Seki, N., Sudo, Y., Mizuhara, H., Orito, K., Imasaki, A., Ono, S., Hamaoka, T., Senoh, H., and Fujiwara, H. (1992) Type II collagen-induced murine arthritis: induction of arthritis depends on antigen-presenting cell function as well as susceptibility of host to an anticollagen immune response. J. Immunol. 148, 3093–3099.
Durie, F. H., Aruffo, A., Ledbetter, J., Crassi, K. M., Green, W. R., Fast, L. D., and Noelle, R. J. (1994) Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J. Clin. Invest. 94, 1333–1338.
Buhlmann, J. E., Foy, T. M., Aruffo, A., Crassi, K. M., Ledbetter, J. A., Green, W. R., Xu, J. C., Shultz, L. D., Roopesian, D., Flavell, R. A., Fast, L., Noelle, R. J., and Durie, F. H. (1995) In the absence of a CD40 signal, B cells are tolerogenic. Immunity 2, 645–653.
Parker, D. C., Greiner, D. L., Phillips, N. E.., Appel, M. C., Steele, A. W., Durie, F. H., Noelle, R. J., Mordes, J. P., and Rossini, A. A. (1995) Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. USA 92, 9560–9564.
Callard, R. E., Armitage, R. J., Fanslow, W. C., and Spriggs, M. K. (1993) CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today 14, 559–564.
Notarangelo, L. D., Duse, M., and Ugazio, A. G. (1992) Immunodeficiency with hyper-IgM (HIM). Immunodefic. Rev. 3, 101–121.
Wiley, J. A. and Harmsen, A. G. (1995) CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J. Immunol. 155, 3525–3529.
Renshaw, B., Fanslow, W. C., III, Armitage, R. J., Campbell, K. A., Liggitt, D., Wright, B., Davison, B., and Maliszewski, C. R. (1994) Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180, 1889–1900.
Xu, J., Foy, T. M., Laman, J. D., Elliott, E. A., Dunn, J. J., Waldschmidt, T. J., Elsemore, J., Noelle, R. J., and Flavell, R. A. (1994) Mice deficient for the CD40 ligand. Immunity 1, 423–431.
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., and Kikutani, H. (1994) The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167–178.
Kennedy, M. K., Picha, K. S., Fanslow, W. C., Grabstein, K. H., Alderson, M. R., Clifford, K. N., Chin, W. A., and Mohler, K. M. (1995) CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol. 26, 370–378.
Shanebeck, K. D., Maliszewski, C. R., Kennedy, M. K., Picha, K. S., Smith, C. A., Goodwin, R. G., and Grabstein, K. H. (1995) Regulation of murine B cell growth and differentiation by CD30 ligand. Eur. J. Immunol. 25, 2147–2153.
Smith, C. A., Gruss, H.-J., Davis, T., Anderson, D., Farrah, T., Baker, E., Sutherland, G. R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., Grabstein, K. H., Gliniak, B., McAlister, I. B., Fanslow, W., Alderson, M., Falk, B., Gimpel, S., Gillis, S., Din, W. S., Goodwin, R. G., and Armitage, R. J. (1993) CD30 antigen, a marker for Hodgkin’s lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73, 1349–1360.
Perlmutter, R. M., Hamburg, D., Briles, D. E., Nicolotti, R. A., and Davie, J. M. (1978) Subclass restriction of murine anti-carbohydrate antibodies. J. Immunol. 121, 566–572.
Mond, J. J. and Brunswick, M. (1987) A role for IFN-y and NK cells in immune responses to T cell-regulated antigens types 1 and 2. Immunol. Rev. 99, 105–118.
Aversa, G., Punnonen, J., and de Vries, J. E. (1993) The 26-kD transmembrane form of tumor necrosis factor a on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177, 1575–1585.
Gray, D., Dullforce, P., and Jainandunsing, S. (1994) Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40–CD40ligand interaction. J. Exp. Med. 180, 141–155.
Gray, D., Siepmann, K., and Wohlleben, G. (1994) CD40 ligation in B cell activation, isotype switching and memory development. Semin. Immunol. 6, 303–310.
Peçanha, L. M. T., Snapper, C. M., Finkelman, F D, and Mond, J. J. (1991) Dextran-conjugated anti-Ig antibodies as a model for T cell-independent type 2 antigen-mediated stimulation of Ig secretion in vitro. I. Lymphokine dependence. J. Immunol. 146, 833–839.
Snapper, C. M. and Mond, J. J. (1993) Towards a comprehensive view of immunoglobulin class switching. Immunol. Today 14, 15–17.
Foy, T. M. and Waldschmidt, T. J. (1993) Switching capacity of FcERIIpositive and -negative murine B cells. Eur. J. Immunol. 23, 3208–3216.
Haughton, G., Arnold, L. W., Whitmore, A. C., and Clarke, S. H. (1993) B-1 cells are made, not born. Immunol. Today 14, 84–87.
Reiner, S. L. and Locksley, R. M. (1995) The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13, 151–177.
Campbell, K. A., Ovendale, P. J., Fanslow, W. C., Reed, S. G., and Maliszewski, C. R. (1996) CD40L is required to generate a protective cell-mediated immune response to Leishmania major. Immunity 4, 283–289.
Hsieh, C.-S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O’Garra, A., and Murphy, K. M. (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547–549.
Seder, R. A. and Paul, W. E. (1994) Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12, 635–673.
Trinchieri, G. (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251–276.
Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L., and Locksley, R. M. (1989) Reciprocal expression of interferon y or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169, 59–72.
Sypek, J. P., Chung, C. L., Mayor, S. E. H., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. F., and Schaub, R. G. (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177, 1797–1802.
Green, S. J., Nacy, C. A., and Meltzer, M. S. (1991) Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J. Leukoc. Biol. 50, 93–103.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Maliszewski, C.R., Kennedy, M.K., Campbell, K.A. (1998). CD40 Ligand Knockout Mice. In: Durum, S.K., Muegge, K. (eds) Cytokine Knockouts. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4757-2753-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2753-1_4
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-2755-5
Online ISBN: 978-1-4757-2753-1
eBook Packages: Springer Book Archive